File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Structural properties of glucan from Russula griseocarnosa and its immunomodulatory activities mediated via T cell differentiation

TitleStructural properties of glucan from Russula griseocarnosa and its immunomodulatory activities mediated via T cell differentiation
Authors
KeywordsAKT/mTOR signaling
Immunity-enhancement
Macrophage polarization
Russula griseocarnosa polysaccharide
T cell differentiation
Issue Date1-Sep-2024
PublisherElsevier
Citation
Carbohydrate Polymers, 2024, v. 339 How to Cite?
Abstract

The polysaccharide, RGP2, was isolated from Russula griseocarnosa and its immunostimulatory effects were confirmed in cyclophosphamide (CTX)-induced immunosuppressed mice. Following purification via chromatography, structural analysis revealed that RGP2 had a molecular weight of 11.82 kDa and consisted of glucose (Glc), galactose (Gal), mannose, glucuronic acid and glucosamine. Bond structure analysis and nuclear magnetic resonance characterization confirmed that the main chain of RGP2 was formed by →6)-β-D-Glcp-(1→, →3)-β-D-Glcp-(1→ and →6)-α-D-Galp-(1→, which was substituted at O-3 of →6)-β-D-Glcp-(1→ by β-D-Glcp-(1→. RGP2 was found to ameliorate pathological damage in the spleen and enhance immune cell activity in immunosuppressed mice. Based on combined multiomics analysis, RGP2 altered the abundance of immune-related microbiota (such as Lactobacillus, Faecalibacterium, and Bacteroides) in the gut and metabolites (uridine, leucine, and tryptophan) in the serum. Compared with immunosuppressed mice, RGP2 also restored the function of antigen-presenting cells, promoted the polarization of macrophages into the M1 phenotype, positively affected the differentiation of helper T cells, and inhibited regulatory T cell differentiation through the protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) pathway, ultimately exerting an immune boosting function. Overall, our findings highlight therapeutic strategies to alleviate CTX-induced immunosuppression in a clinical setting.


Persistent Identifierhttp://hdl.handle.net/10722/358453
ISSN
2023 Impact Factor: 10.7
2023 SCImago Journal Rankings: 1.831

 

DC FieldValueLanguage
dc.contributor.authorLiu, Xin-
dc.contributor.authorDong, Mingyuan-
dc.contributor.authorLi, Yuan-
dc.contributor.authorLi, Lanzhou-
dc.contributor.authorZhang, Yongfeng-
dc.contributor.authorWang, Chunyue-
dc.contributor.authorWang, Ning-
dc.contributor.authorWang, Di-
dc.date.accessioned2025-08-07T00:32:25Z-
dc.date.available2025-08-07T00:32:25Z-
dc.date.issued2024-09-01-
dc.identifier.citationCarbohydrate Polymers, 2024, v. 339-
dc.identifier.issn0144-8617-
dc.identifier.urihttp://hdl.handle.net/10722/358453-
dc.description.abstract<p>The polysaccharide, RGP2, was isolated from Russula griseocarnosa and its immunostimulatory effects were confirmed in cyclophosphamide (CTX)-induced immunosuppressed mice. Following purification via chromatography, structural analysis revealed that RGP2 had a molecular weight of 11.82 kDa and consisted of glucose (Glc), galactose (Gal), mannose, glucuronic acid and glucosamine. Bond structure analysis and nuclear magnetic resonance characterization confirmed that the main chain of RGP2 was formed by →6)-β-D-Glcp-(1→, →3)-β-D-Glcp-(1→ and →6)-α-D-Galp-(1→, which was substituted at O-3 of →6)-β-D-Glcp-(1→ by β-D-Glcp-(1→. RGP2 was found to ameliorate pathological damage in the spleen and enhance immune cell activity in immunosuppressed mice. Based on combined multiomics analysis, RGP2 altered the abundance of immune-related microbiota (such as Lactobacillus, Faecalibacterium, and Bacteroides) in the gut and metabolites (uridine, leucine, and tryptophan) in the serum. Compared with immunosuppressed mice, RGP2 also restored the function of antigen-presenting cells, promoted the polarization of macrophages into the M1 phenotype, positively affected the differentiation of helper T cells, and inhibited regulatory T cell differentiation through the protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) pathway, ultimately exerting an immune boosting function. Overall, our findings highlight therapeutic strategies to alleviate CTX-induced immunosuppression in a clinical setting.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofCarbohydrate Polymers-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAKT/mTOR signaling-
dc.subjectImmunity-enhancement-
dc.subjectMacrophage polarization-
dc.subjectRussula griseocarnosa polysaccharide-
dc.subjectT cell differentiation-
dc.titleStructural properties of glucan from Russula griseocarnosa and its immunomodulatory activities mediated via T cell differentiation-
dc.typeArticle-
dc.identifier.doi10.1016/j.carbpol.2024.122214-
dc.identifier.pmid38823900-
dc.identifier.scopuseid_2-s2.0-85192336326-
dc.identifier.volume339-
dc.identifier.eissn1879-1344-
dc.identifier.issnl0144-8617-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats